subject: CHEBI:62880

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:62880

subject_name: Veliparib

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7

tested_intervention: unsure


subject: CHEBI:62880

object_name: fallopian tube mucinous adenocarcinoma


subject: CHEBI:62880

object_name: fallopian tube clear cell adenocarcinoma


subject: CHEBI:62880

object_name: fallopian tube endometrioid adenocarcinoma


subject: CHEBI:62880

object_name: ovarian seromucinous tumor


subject: CHEBI:62880

object_name: ovarian Brenner tumor


subject: CHEBI:62880

object_name: ovarian transitional cell carcinoma


subject: CHEBI:62880

object_name: ovarian carcinosarcoma


subject: CHEBI:62880

object_name: Primary mucinous adenocarcinoma of ovary


subject: CHEBI:62880

object_name: ovarian mucinous adenocarcinoma


subject: CHEBI:62880

object_name: ovarian clear cell adenocarcinoma


subject: CHEBI:62880

object_name: ovarian serous adenocarcinoma


subject: UMLS:C5784758

subject_name: Dazukibart

object_name: cutaneous lupus erythematosus

tested_intervention: yes


subject: UMLS:C5784758

object_name: EXCESS LMW-DNA


subject: CHEBI:93776

subject_name: Pevonedistat

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UNII:0661V34NTV

object_name: Cognitive impairment


subject: UMLS:C5959765

subject_name: TEAD Inhibitor SW-682


subject: UMLS:C5959765

object_name: malignant mesothelioma


subject: UMLS:C0699617

subject_name: Norditropin

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C0699617

object_name: metabolic syndrome X


subject: UMLS:C0918027

object_name: lymphatic malformation


subject: CHEBI:190523

subject_name: fructooligosaccharide

object_name: Infectious disease of genitourinary system


subject: CHEBI:190523

object_name: Birth weight <2500gm


subject: MESH:C116580


subject: MESH:C116580


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid

object_name: Solid carcinoma


subject: PUBCHEM.COMPOUND:135402009

object_name: squamous cell carcinoma of penis


subject: PUBCHEM.COMPOUND:135402009

object_name: cervical squamous cell carcinoma


subject: PUBCHEM.COMPOUND:135402009

object_name: vulvar squamous cell carcinoma


subject: PUBCHEM.COMPOUND:135402009

object_name: anal squamous cell carcinoma


subject: PUBCHEM.COMPOUND:135402009

object_name: endometrium adenocarcinoma


subject: PUBCHEM.COMPOUND:135402009

object_name: small cell lung carcinoma


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:177298

object_name: Stomach cancer


subject: CHEBI:177298

object_name: gastric cancer


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:177298

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:177298

object_name: squamous cell carcinoma


subject: CHEBI:177298

object_name: gastric adenocarcinoma


subject: CHEBI:177298

object_name: carcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: UMLS:C1705207

subject_name: Endostar

object_name: nasopharyngeal neoplasm


subject: PUBCHEM.COMPOUND:71300864

object_name: neoplasm


subject: UMLS:C2933615

subject_name: LCZ 696


subject: UMLS:C5203921

subject_name: Lutetium Lu 177-NeoB


subject: UMLS:C4733618

subject_name: Gallium Ga 68-NeoB


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Chronic pain due to injury


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C5221254

subject_name: Ciprofloxacin/ Fluocinolone Acetonide

object_name: beach ear


subject: UMLS:C5557489

subject_name: TLR 7/8 Antagonist M5049


subject: UNII:G22FG6Q00B

subject_name: enisamium iodide

object_name: influenza


subject: CHEBI:2453

subject_name: Acyclovir

object_name: HIV Seronegativity


subject: CHEBI:6741

subject_name: Meloxicam

object_name: non-Hodgkin lymphoma


subject: CHEBI:6741

object_name: plasma cell myeloma


subject: CHEBI:49140

object_name: Pick Complex


subject: CHEBI:49140

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:49140

object_name: frontotemporal dementia


subject: CHEBI:49140

object_name: Pick disease


subject: CHEBI:49140

object_name: Alzheimer disease


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: UNII:6867Q6IKOD

subject_name: FLORBETAPIR


subject: UNII:6867Q6IKOD


subject: UNII:6867Q6IKOD


subject: UNII:6867Q6IKOD


subject: UMLS:C0541491

subject_name: Drugs and Biologicals

object_name: asthma


subject: CHEBI:91899

object_name: collagenous colitis


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:63626

subject_name: Tesamorelin

object_name: traumatic encephalopathy


subject: CHEBI:63626

object_name: traumatic brain injury


subject: CHEBI:63626

object_name: sleep disorder


subject: UMLS:C1313807


subject: UMLS:C1313807


subject: UMLS:C1313807


subject: CHEBI:24848

subject_name: inositol

object_name: anovulation


subject: CHEBI:24848

object_name: Female infertility associated with anovulation


subject: UMLS:C1565751

object_name: kidney failure


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:184662

object_name: metastatic colorectal cancer


subject: CHEBI:184662

object_name: Marinesco-Sjogren syndrome


subject: CHEBI:184662

object_name: Microsatellite Stable


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEMBL.COMPOUND:CHEMBL256907


subject: CHEMBL.COMPOUND:CHEMBL256907


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:63608


subject: CHEBI:63608


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: familial Dupuytren contracture


subject: PUBCHEM.COMPOUND:633097

object_name: palmar fibromatosis


subject: PUBCHEM.COMPOUND:633097

object_name: Dupuytren's contracture (physical finding)


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:43636

object_name: coronary microvascular disorder


subject: CHEBI:43636

object_name: hypertension


subject: CHEBI:170007

subject_name: Nirmatrelvir

object_name: Safety Issues


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Colon Neoplasm


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: triple-negative breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: UMLS:C4086994


subject: UMLS:C2976285

subject_name: TAK 438

object_name: Non-erosive gastro-esophageal reflux disease


subject: CHEMBL.COMPOUND:CHEMBL4297728

subject_name: CIRMTUZUMAB

object_name: breast neoplasm


subject: UMLS:C3896753


subject: CHEBI:4672

subject_name: Docetaxel

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UMLS:C1614968

subject_name: Sativex

object_name: Encounter due to care involving use of rehabilitation procedures


subject: UMLS:C5238912

subject_name: Anti-CD137 Agonistic Monoclonal Antibody AGEN2373

object_name: pancreatic neoplasm


subject: UMLS:C5238912

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5238912

object_name: malignant pancreatic neoplasm


subject: UMLS:C5761796

subject_name: GVAX


subject: UMLS:C5761796


subject: UMLS:C5761796


subject: CHEBI:83605

object_name: HIV infection


subject: CHEBI:53232

subject_name: polyimide macromolecule


subject: CHEBI:456215

subject_name: adenosine 5'-monophosphate(2-)


subject: CHEBI:28931


subject: PUBCHEM.COMPOUND:53481006

subject_name: Adenosine 2'-phosphate


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:16335

subject_name: Adenosine


subject: UMLS:C4084937

subject_name: Antimicrobial Peptide


subject: UMLS:C4285220

subject_name: Absorbable Modified Polymer Hemostatic Powder


subject: UMLS:C4551608

subject_name: Sevorane

object_name: Other functional disturbances following cardiac surgery


subject: UMLS:C4551608

object_name: Memory Disorders


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:3561

subject_name: Cetirizine

object_name: sarcoma


subject: CHEBI:188074


subject: CHEBI:85993

subject_name: Palbociclib

object_name: Childhood Neuroblastoma


subject: CHEBI:85993

object_name: neuroblastoma


subject: CHEBI:85993

object_name: Ewing sarcoma


subject: CHEBI:85993

object_name: medulloblastoma


subject: CHEBI:85993

object_name: childhood medulloblastoma


subject: CHEBI:85993

object_name: adult medulloblastoma


subject: CHEBI:85993

object_name: rhabdoid tumor


subject: CHEBI:85993

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:85993

object_name: rhabdomyosarcoma


subject: CHEBI:85993

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:85993

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:85993

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:85993

object_name: diffuse intrinsic pontine glioma


subject: UNII:DLG4EML025

subject_name: Secukinumab

object_name: Necrobiosis Lipoidica Diabeticorum


subject: CHEBI:32599

object_name: Severe Sepsis


subject: CHEBI:32599

object_name: septic shock


subject: PUBCHEM.COMPOUND:16129616

subject_name: Calcitonin

object_name: osteoarthritis


subject: CHEMBL.COMPOUND:CHEMBL461806

subject_name: ELTROMBOPAG OLAMINE

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: UMLS:C1880492

subject_name: eltrombopag olamine


subject: UMLS:C1880492


subject: UMLS:C1880492


subject: DRUGBANK:DB16462

object_name: severe acute respiratory syndrome


subject: UMLS:C2093102

subject_name: milrinone injection (medication)

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: CHEBI:50693

subject_name: Milrinone


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: diabetes mellitus


subject: UNII:UC95NQ339C

object_name: peripheral nervous system disorder


subject: UNII:UC95NQ339C

object_name: neuropathy


subject: UNII:UC95NQ339C

object_name: Plantar Ulcer


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: CHEBI:47381

subject_name: Diclofenac

object_name: Laceration of perineum


subject: CHEBI:47381

object_name: Obstetrical laceration


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: CHEBI:6413

subject_name: Letrozole

object_name: constitutional delay of growth and puberty


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: UMLS:C3864947

subject_name: Gardasil 9

object_name: high grade vulvar squamous intraepithelial lesion


subject: UMLS:C3864947

object_name: Vulval intraepithelial neoplasia grade 2


subject: UMLS:C3864947

object_name: High Grade Anal Canal Intraepithelial Neoplasia


subject: UMLS:C2827536

subject_name: DEC-205/NY-ESO-1 Fusion Protein CDX-1401

object_name: small cell lung carcinoma


subject: UMLS:C2827536

object_name: melanoma


subject: UMLS:C2827536

object_name: Mesothelioma


subject: UMLS:C2827536

object_name: mesothelial neoplasm


subject: UMLS:C2827536

object_name: malignant mesothelioma


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: CHEBI:7575

subject_name: Nimodipine

object_name: infertility


subject: CHEBI:2654

subject_name: Aminoglutethimide

object_name: Early Stage Breast Carcinoma


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: pseudomyxoma peritonei


subject: CHEBI:22198

object_name: peritoneum cancer


subject: CHEBI:22198

object_name: mucinous neoplasm


subject: CHEBI:22198

object_name: mucinous adenocarcinoma


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:17561


subject: PUBCHEM.COMPOUND:74981710

subject_name: Bromelain


subject: PUBCHEM.COMPOUND:74981710


subject: PUBCHEM.COMPOUND:74981710


subject: PUBCHEM.COMPOUND:74981710


subject: UMLS:C0006217

subject_name: bromelains


subject: UMLS:C0006217


subject: UMLS:C0006217


subject: UMLS:C0293742

subject_name: stem bromelain


subject: UMLS:C0293742


subject: UMLS:C0293742


subject: UMLS:C0293742


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: radiculopathy


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:94366

subject_name: itraconazole

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:94366

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:94366

object_name: diffuse large B-cell lymphoma


subject: CHEBI:94366

object_name: kidney medullary carcinoma


subject: CHEBI:94366

object_name: collecting duct carcinoma


subject: CHEBI:94366

object_name: Childhood Synovial Sarcoma


subject: CHEBI:94366

object_name: Adult Synovial Sarcoma


subject: CHEBI:94366

object_name: synovial sarcoma


subject: CHEBI:94366

object_name: Mesothelioma


subject: CHEBI:94366

object_name: mesothelial neoplasm


subject: CHEBI:94366

object_name: malignant mesothelioma


subject: CHEBI:94366

object_name: rhabdoid tumor


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673


subject: PUBCHEM.COMPOUND:135512673


subject: PUBCHEM.COMPOUND:135512673


subject: PUBCHEM.COMPOUND:135512673


subject: PUBCHEM.COMPOUND:135512673


subject: PUBCHEM.COMPOUND:135512673


subject: PUBCHEM.COMPOUND:135512673


subject: PUBCHEM.COMPOUND:135512673


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: HMDB:HMDB0015179


subject: CHEBI:231598

subject_name: Tazemetostat


subject: CHEBI:231598

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:231598


subject: CHEBI:231598

object_name: Childhood Solid Neoplasm


subject: CHEBI:231598

object_name: Solid Neoplasm


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: esophageal adenocarcinoma


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: CHEBI:16856

subject_name: Glutathione

object_name: malnutrition


subject: UMLS:C5834390

subject_name: Liposomal glutathione


subject: UMLS:C1258613

subject_name: oblimersen sodium

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C1258613

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UMLS:C1258613

object_name: Mantle cell lymphoma stage IV


subject: UMLS:C1258613

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UMLS:C1258613

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C1258613

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C1258613

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UMLS:C1258613

object_name: Stage IV Adult Burkitt Lymphoma


subject: UMLS:C1258613

object_name: Marginal zone lymphoma stage IV


subject: UMLS:C1258613

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C1258613

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C1258613

object_name: recurrent cutaneous T-cell lymphoma


subject: UMLS:C1258613

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UMLS:C1258613

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UMLS:C1258613

object_name: Cutaneous T-cell lymphoma stage IV


subject: UMLS:C1258613

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: UNII:WB59MRW00U

object_name: acute myeloid leukemia


subject: UNII:WB59MRW00U

object_name: adult acute myeloid leukemia


subject: UNII:WB59MRW00U

object_name: acute myelogenous leukemia in relapse


subject: UNII:WB59MRW00U

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:231679

object_name: stage IV pancreatic cancer


subject: GTOPDB:4934

subject_name: G-CSF

object_name: mixed germ cell tumor


subject: GTOPDB:4934

object_name: ovarian mixed germ cell neoplasm


subject: GTOPDB:4934

object_name: mixed testicular germ cell cancer


subject: GTOPDB:4934

object_name: nongerminomatous germ cell tumor


subject: GTOPDB:4934

object_name: malignant germ cell tumor


subject: GTOPDB:4934

object_name: yolk sac tumor


subject: GTOPDB:4934

object_name: adult yolk sac tumor


subject: GTOPDB:4934

object_name: testicular yolk sac tumor


subject: GTOPDB:4934

object_name: ovarian yolk sac tumor


subject: GTOPDB:4934

object_name: vaginal yolk sac tumor


subject: GTOPDB:4934

object_name: extragonadal seminoma


subject: GTOPDB:4934

object_name: central nervous system germinoma


subject: GTOPDB:4934

object_name: pineal region germinoma


subject: GTOPDB:4934

object_name: germinoma


subject: GTOPDB:4934

object_name: Childhood Teratoma


subject: GTOPDB:4934

object_name: uterine corpus choriocarcinoma


subject: GTOPDB:4934

object_name: choriocarcinoma of testis


subject: GTOPDB:4934

object_name: choriocarcinoma


subject: GTOPDB:4934

object_name: seminoma


subject: GTOPDB:4934

object_name: testicular germ cell tumor


subject: GTOPDB:4934

object_name: testis seminoma


subject: GTOPDB:4934

object_name: adult teratoma


subject: GTOPDB:4934

object_name: teratoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: mixed germ cell tumor


subject: UNII:PVI5M0M1GW

object_name: ovarian mixed germ cell neoplasm


subject: UNII:PVI5M0M1GW

object_name: mixed testicular germ cell cancer


subject: UNII:PVI5M0M1GW

object_name: nongerminomatous germ cell tumor


subject: UNII:PVI5M0M1GW

object_name: malignant germ cell tumor


subject: UNII:PVI5M0M1GW

object_name: yolk sac tumor


subject: UNII:PVI5M0M1GW

object_name: adult yolk sac tumor


subject: UNII:PVI5M0M1GW

object_name: vaginal yolk sac tumor


subject: UNII:PVI5M0M1GW

object_name: extragonadal seminoma


subject: UNII:PVI5M0M1GW

object_name: central nervous system germinoma


subject: UNII:PVI5M0M1GW

object_name: pineal region germinoma


subject: UNII:PVI5M0M1GW

object_name: germinoma


subject: UNII:PVI5M0M1GW

object_name: uterine corpus choriocarcinoma


subject: UNII:PVI5M0M1GW

object_name: choriocarcinoma


subject: UNII:PVI5M0M1GW

object_name: seminoma


subject: UNII:PVI5M0M1GW

object_name: testis seminoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:31355

subject_name: Carboplatin

object_name: adult germ cell tumor


subject: CHEBI:31355

object_name: germ cell tumor


subject: CHEBI:31355

object_name: Germ Cell Cancer


subject: CHEBI:31355

object_name: mixed germ cell tumor


subject: CHEBI:31355

object_name: ovarian mixed germ cell neoplasm


subject: CHEBI:31355

object_name: mixed testicular germ cell cancer


subject: CHEBI:31355

object_name: nongerminomatous germ cell tumor


subject: CHEBI:31355

object_name: malignant germ cell tumor


subject: CHEBI:31355

object_name: yolk sac tumor


subject: CHEBI:31355

object_name: adult yolk sac tumor


subject: CHEBI:31355

object_name: vaginal yolk sac tumor


subject: CHEBI:31355

object_name: extragonadal seminoma


subject: CHEBI:31355

object_name: germinoma


subject: CHEBI:31355

object_name: uterine corpus choriocarcinoma


subject: CHEBI:31355

object_name: choriocarcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: testicular yolk sac tumor


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: central nervous system germinoma


subject: PUBCHEM.COMPOUND:2767

object_name: pineal region germinoma


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: choriocarcinoma of testis


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767

object_name: adult teratoma


subject: PUBCHEM.COMPOUND:2767

object_name: teratoma


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate

object_name: adult germ cell tumor


subject: PUBCHEM.COMPOUND:16760419

object_name: germ cell tumor


subject: PUBCHEM.COMPOUND:16760419

object_name: Germ Cell Cancer


subject: PUBCHEM.COMPOUND:16760419

object_name: mixed germ cell tumor


subject: PUBCHEM.COMPOUND:16760419

object_name: ovarian mixed germ cell neoplasm


subject: PUBCHEM.COMPOUND:16760419

object_name: mixed testicular germ cell cancer


subject: PUBCHEM.COMPOUND:16760419

object_name: nongerminomatous germ cell tumor


subject: PUBCHEM.COMPOUND:16760419

object_name: malignant germ cell tumor


subject: PUBCHEM.COMPOUND:16760419

object_name: yolk sac tumor


subject: PUBCHEM.COMPOUND:16760419

object_name: adult yolk sac tumor


subject: PUBCHEM.COMPOUND:16760419


subject: PUBCHEM.COMPOUND:16760419

object_name: ovarian yolk sac tumor


subject: PUBCHEM.COMPOUND:16760419

object_name: vaginal yolk sac tumor


subject: PUBCHEM.COMPOUND:16760419

object_name: extragonadal seminoma


subject: PUBCHEM.COMPOUND:16760419

object_name: central nervous system germinoma


subject: PUBCHEM.COMPOUND:16760419

object_name: pineal region germinoma


subject: PUBCHEM.COMPOUND:16760419

object_name: germinoma


subject: PUBCHEM.COMPOUND:16760419

object_name: Childhood Teratoma


subject: PUBCHEM.COMPOUND:16760419

object_name: uterine corpus choriocarcinoma


subject: PUBCHEM.COMPOUND:16760419

object_name: choriocarcinoma of testis


subject: PUBCHEM.COMPOUND:16760419

object_name: choriocarcinoma


subject: PUBCHEM.COMPOUND:16760419

object_name: seminoma


subject: PUBCHEM.COMPOUND:16760419

object_name: testis seminoma


subject: PUBCHEM.COMPOUND:16760419

object_name: adult teratoma


subject: PUBCHEM.COMPOUND:16760419

object_name: teratoma


subject: CHEBI:4911

subject_name: Etoposide

object_name: mixed germ cell tumor


subject: CHEBI:4911

object_name: ovarian mixed germ cell neoplasm


subject: CHEBI:4911

object_name: mixed testicular germ cell cancer


subject: CHEBI:4911

object_name: malignant germ cell tumor


subject: CHEBI:4911

object_name: yolk sac tumor


subject: CHEBI:4911

object_name: adult yolk sac tumor


subject: CHEBI:4911

object_name: testicular yolk sac tumor


subject: CHEBI:4911

object_name: vaginal yolk sac tumor


subject: CHEBI:4911

object_name: extragonadal seminoma


subject: CHEBI:4911

object_name: germinoma


subject: CHEBI:4911

object_name: uterine corpus choriocarcinoma


subject: CHEBI:4911

object_name: choriocarcinoma of testis


subject: CHEBI:4911

object_name: choriocarcinoma


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864

object_name: nongerminomatous germ cell tumor


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864

object_name: central nervous system germinoma


subject: CHEBI:5864

object_name: pineal region germinoma


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864

object_name: seminoma


subject: CHEBI:5864

object_name: testis seminoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: mixed germ cell tumor


subject: CHEBI:45863

object_name: ovarian mixed germ cell neoplasm


subject: CHEBI:45863

object_name: mixed testicular germ cell cancer


subject: CHEBI:45863


subject: CHEBI:45863

object_name: malignant germ cell tumor


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: adult germ cell tumor


subject: UNII:3A58010674

object_name: germ cell tumor


subject: UNII:3A58010674

object_name: childhood germ cell tumor


subject: UNII:3A58010674

object_name: Germ Cell Cancer


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674

object_name: yolk sac tumor


subject: UNII:3A58010674

object_name: adult yolk sac tumor


subject: UNII:3A58010674

object_name: testicular yolk sac tumor


subject: UNII:3A58010674

object_name: ovarian yolk sac tumor


subject: UNII:3A58010674

object_name: vaginal yolk sac tumor


subject: UNII:3A58010674

object_name: extragonadal seminoma


subject: UNII:3A58010674

object_name: central nervous system germinoma


subject: UNII:3A58010674

object_name: pineal region germinoma


subject: UNII:3A58010674

object_name: germinoma


subject: UNII:3A58010674

object_name: Childhood Teratoma


subject: UNII:3A58010674

object_name: uterine corpus choriocarcinoma


subject: UNII:3A58010674

object_name: choriocarcinoma of testis


subject: UNII:3A58010674

object_name: choriocarcinoma


subject: UNII:3A58010674

object_name: seminoma


subject: UNII:3A58010674

object_name: testis seminoma


subject: UNII:3A58010674

object_name: adult teratoma


subject: UNII:3A58010674

object_name: teratoma


subject: UMLS:C1099479

subject_name: Alloderm

object_name: breast neoplasm


subject: UMLS:C3658621

subject_name: FlexHD


subject: CHEBI:73612

subject_name: Met-Pro

object_name: congenital heart disease


subject: UNII:BE9PTC7J7P

subject_name: MP


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:24433

subject_name: group


subject: PUBCHEM.COMPOUND:133604

subject_name: Collagen

object_name: Implant site reaction


subject: KEGG.COMPOUND:C00211


subject: CHEBI:3815


subject: UMLS:C0009325

subject_name: collagen


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Pulmonary vascular resistance abnormality


subject: CHEBI:50859

subject_name: Bexarotene

object_name: follicular lymphoma


subject: CHEBI:50859

object_name: non-Hodgkin lymphoma


subject: CHEBI:50859

object_name: anaplastic large cell lymphoma


subject: CHEBI:50859

object_name: lymphomatoid papulosis


subject: CHEBI:50859

object_name: mycosis fungoides of skin


subject: CHEBI:82354

subject_name: Nitrogen mustard N-oxide

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:82354

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:82354


subject: CHEBI:82354


subject: CHEBI:82354


subject: CHEBI:82354


subject: CHEBI:82354


subject: CHEBI:37598

subject_name: nitrogen mustard


subject: CHEBI:37598


subject: CHEBI:37598


subject: CHEBI:37598


subject: CHEBI:37598


subject: CHEBI:37598


subject: CHEBI:37598


subject: CHEBI:28925

subject_name: Mechlorethamine


subject: CHEBI:28925


subject: CHEBI:28925


subject: CHEBI:28925


subject: CHEBI:28925


subject: CHEBI:28925


subject: CHEBI:28925


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: PUBCHEM.COMPOUND:633097


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:9667


subject: CHEBI:172315

subject_name: Norbuprenorphine

object_name: HIV infection


subject: CHEBI:36704

subject_name: Imiquimod

object_name: Genital warts


subject: CHEBI:36704

object_name: Condyloma anal


subject: CHEBI:91083

subject_name: Romiplostim

object_name: bone marrow failure syndrome


subject: CHEBI:91083

object_name: refractory cytopenia of childhood


subject: UMLS:C1505595


subject: UMLS:C1505595


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Venous Stroke


subject: CHEBI:68579

object_name: Cerebral venous sinus thrombosis


subject: UMLS:C4733612

subject_name: Gentuximab

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:27812

subject_name: Methylselenocysteine

object_name: ischemic cardiomyopathy


subject: MESH:C433370

subject_name: Traumeel S

object_name: Post-Operative Pain


subject: CHEBI:63115

subject_name: Fingolimod

object_name: Inflammation


subject: CHEBI:33283

subject_name: THIAMINE

object_name: lactic acidosis


subject: CHEBI:33283


subject: CHEBI:33283

object_name: lipodystrophy


subject: CHEBI:33283

object_name: AIDS


subject: UMLS:C3714802

subject_name: Thiamine Drug Class


subject: UMLS:C3714802


subject: UMLS:C3714802


subject: UMLS:C3714802


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:18385


subject: CHEBI:18385


subject: CHEBI:18385


subject: CHEBI:57986


subject: CHEBI:57986


subject: CHEBI:57986


subject: CHEBI:57986


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: UMLS:C3714502


subject: UMLS:C3714502


subject: UMLS:C3714502


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17621


subject: CHEBI:17621


subject: CHEBI:17621


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:16347

subject_name: Levocarnitine


subject: CHEBI:16347


subject: CHEBI:16347


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Arm Injuries


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:73770

subject_name: Ala-Leu

object_name: Plasmodium falciparum malaria


subject: CHEBI:73838

subject_name: D-Ala-Leu


subject: CHEBI:30136

subject_name: Aluminium


subject: CHEBI:28984

subject_name: aluminium atom


subject: MESH:C086083


subject: UMLS:C4305754

object_name: rheumatoid arthritis


subject: UMLS:C5400007


subject: UNII:6E01CG547T

subject_name: MITOQUINONE MESYLATE

object_name: Adverse Childhood Experiences


subject: UNII:6E01CG547T

object_name: Increased reactive oxygen species production


subject: UMLS:C5690695

subject_name: mitoquinone mesylate


subject: UMLS:C5690695


subject: UMLS:C5690696

subject_name: MitoQ


subject: UMLS:C5690696


subject: UMLS:C3152625

subject_name: Pneumococcal 13-valent conjugate vaccine

object_name: inflammatory spondylopathy


subject: UMLS:C3152625

object_name: spondyloarthropathy


subject: UMLS:C3152625

object_name: vasculitis


subject: UMLS:C3152625

object_name: Systemic Vasculitis


subject: UMLS:C3152625

object_name: necrotizing vasculitis


subject: UMLS:C3152625

object_name: Sicca Syndrome


subject: MESH:C414006

subject_name: 23-valent pneumococcal capsular polysaccharide vaccine


subject: MESH:C414006


subject: MESH:C414006


subject: MESH:C414006


subject: MESH:C414006


subject: MESH:C414006


subject: MESH:C414006


subject: UNII:B6E7K36KT8

subject_name: Cenegermin

object_name: neuropathy


subject: UNII:B6E7K36KT8

object_name: corneal disease


subject: UMLS:C4731383

subject_name: cenegermin-bkbj


subject: UMLS:C4731383


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Myelodysplasia


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:134506

subject_name: Dehydroandrosterone

object_name: Childhood Synovial Sarcoma


subject: PUBCHEM.COMPOUND:134506

object_name: Adult Synovial Sarcoma


subject: PUBCHEM.COMPOUND:134506

object_name: synovial sarcoma


subject: CHEBI:85252

subject_name: synaptamide


subject: CHEBI:85252


subject: CHEBI:85252


subject: CHEBI:89608

subject_name: Cervonoyl ethanolamide


subject: CHEBI:89608


subject: CHEBI:89608


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: UMLS:C4329339

object_name: Neoplasms, Multiple Primary


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Malignant ascites


subject: UNII:6XC1PAD3KF

object_name: gastric adenocarcinoma


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:233197

subject_name: devimistat

object_name: clear cell sarcoma


subject: UMLS:C2703200

subject_name: CPI 613


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:93775

subject_name: Amethopterin

object_name: metastatic colorectal cancer


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:PUY08529FK

subject_name: Eleclazine

object_name: long QT syndrome 2


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: malignant mesothelioma


subject: UNII:7XL5ISS668

object_name: CD30-Positive Neoplastic Cells Present


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:9316

subject_name: Sufentanil

object_name: Pregnant


subject: UMLS:C0042210

subject_name: Vaccines

object_name: Recurrent vulvovaginal candidiasis


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: blepharospasm


subject: UMLS:C3714119

object_name: ovarian cancer


subject: UMLS:C3714119

object_name: ovarian neoplasm


subject: UMLS:C3714119

object_name: ovarian carcinoma


subject: UMLS:C3714119

object_name: fallopian tube carcinoma


subject: UMLS:C3714119

object_name: fallopian tube cancer


subject: UMLS:C3714119

object_name: fallopian tube neoplasm


subject: UMLS:C5856158

subject_name: Ametumumab

object_name: colorectal cancer


subject: UMLS:C5856158

object_name: colorectal carcinoma


subject: UMLS:C5856158

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody


subject: UMLS:C4289970


subject: UMLS:C4289970


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: HIV infection


subject: CHEBI:62880

subject_name: Veliparib

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C1725733

subject_name: ACB (Acebutolol)

object_name: Post-Operative Pain


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Crohn disease


subject: GTOPDB:4934

subject_name: G-CSF


subject: PUBCHEM.COMPOUND:154975891

object_name: grade II glioma


subject: PUBCHEM.COMPOUND:154975891

object_name: IDH gene mutation


subject: UMLS:C5706380

subject_name: EBP Inhibitor DSP-0390


subject: UMLS:C5706380


subject: UNII:RB55ZW48XG


subject: UNII:RB55ZW48XG


subject: CHEBI:109549

subject_name: Ramelteon

object_name: Ability to balance


subject: CHEBI:499361

subject_name: Aprepitant

object_name: digestive system cancer


subject: CHEBI:6801

subject_name: Metformin

object_name: focal segmental glomerulosclerosis


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: lipoid nephrosis


subject: CHEBI:168243

object_name: idiopathic nephrotic syndrome


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: Complication of transplanted lung


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: viral disease


subject: CHEBI:46245

object_name: Eosinophilic myocarditis


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:6375

subject_name: Lansoprazole


subject: CHEBI:6375


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE


subject: PUBCHEM.COMPOUND:9800288


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: CHEBI:7565

subject_name: Nifedipine


subject: CHEBI:7565


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:230570


subject: CHEBI:230570


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: osteoarthritis


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Asperger syndrome


subject: CHEBI:5002

subject_name: Fenoldopam

object_name: hypertension


subject: CHEBI:5002

object_name: Hypertension, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5314951

subject_name: SONROTOCLAX

object_name: chronic leukemia


subject: UNII:30R67U9KYS


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: CHEBI:17026

subject_name: Progesterone

object_name: psychosis


subject: CHEBI:17026

object_name: Nonorganic psychosis


subject: CHEBI:17026

object_name: Psychosis, CTCAE


subject: CHEBI:17026

object_name: Anhedonia


subject: UMLS:C0752264

subject_name: Raclopride C11


subject: UMLS:C0752264


subject: UMLS:C0752264


subject: UMLS:C0752264


subject: UMLS:C0752264

object_name: Depressed mood


subject: UMLS:C0752264

object_name: Cancer patients and suicide and depression


subject: UMLS:C0752264

object_name: Depressed - symptom


subject: UMLS:C0752264

object_name: Depression, CTCAE


subject: CHEBI:90620

subject_name: Vatalanib

object_name: von Hippel-Lindau disease


subject: CHEBI:90620

object_name: Hemangioblastoma of central nervous system


subject: CHEBI:90620

object_name: retinal hemangioblastoma


subject: UMLS:C0912413

subject_name: PTK 787


subject: UMLS:C0912413


subject: UMLS:C0912413


subject: CHEBI:90623


subject: CHEBI:90623


subject: CHEBI:90623


subject: UMLS:C1524078


subject: UMLS:C1524078


subject: UMLS:C1524078


subject: GTOPDB:5962

subject_name: dovitinib

object_name: recurrent pheochromocytoma


subject: GTOPDB:5962

object_name: Recurrent Paraganglioma


subject: GTOPDB:5962

object_name: Unresectable Paraganglioma


subject: CHEBI:63627

subject_name: Tinidazole

object_name: vaginitis


subject: CHEBI:63627

object_name: candidiasis


subject: CHEBI:3764

subject_name: Clotrimazole


subject: CHEBI:3764


subject: CHEBI:15366

subject_name: Acetic acid

object_name: pulmonary hypertension


subject: CHEBI:15366

object_name: Pulmonary Hypertension, CTCAE


subject: UNII:V5Y646AW8S

object_name: substance-related disorder


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:6538

subject_name: Loratadine


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Stage III Breast Cancer AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Breast cancer stage III


subject: UNII:52CMI0WC3Y

object_name: Stage III Breast Cancer AJCC v6


subject: UNII:52CMI0WC3Y

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:52CMI0WC3Y

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:52CMI0WC3Y

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Stage IIIA Breast Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IIIB Breast Carcinoma


subject: UNII:52CMI0WC3Y

object_name: HER2/Neu Negative


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:51038893

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:51038893

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:51038893

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:51038893

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:51038893

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:76022323

subject_name: Idasanutlin

object_name: Stage III Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:76022323


subject: PUBCHEM.COMPOUND:76022323

object_name: Breast cancer stage III


subject: PUBCHEM.COMPOUND:76022323

object_name: Stage III Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:76022323

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:76022323

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:76022323


subject: PUBCHEM.COMPOUND:76022323


subject: PUBCHEM.COMPOUND:76022323

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:76022323

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:76022323

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:76022323


subject: PUBCHEM.COMPOUND:76022323


subject: PUBCHEM.COMPOUND:76022323


subject: PUBCHEM.COMPOUND:76022323


subject: PUBCHEM.COMPOUND:76022323

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:76022323

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:76022323


subject: PUBCHEM.COMPOUND:76022323


subject: PUBCHEM.COMPOUND:76022323

object_name: HER2/Neu Negative


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: lung disorder


subject: PUBCHEM.COMPOUND:6096882

object_name: neoplasm of thorax


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Postoperative cognitive dysfunction


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: UMLS:C3896909

object_name: neuroendocrine neoplasm


subject: CHEBI:74705

subject_name: Met-Leu

object_name: atrial fibrillation


subject: CHEBI:74705

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:74705

object_name: Atrial Fibrillation, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: UMLS:C2740858

subject_name: BPS

object_name: conscious sedation failure during procedure


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED

object_name: Inflammation


subject: CHEBI:135983

subject_name: Teriparatide

object_name: Fractured ankle


subject: CHEBI:50249

subject_name: anticoagulant

object_name: Myocardial infarction due to demand ischemia


subject: UMLS:C0003280

subject_name: Anticoagulants


subject: CHEBI:72296

subject_name: Apixaban


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: CHEBI:10033

subject_name: Warfarin


subject: UMLS:C0085826

subject_name: Antiplatelet Agents


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:9150

subject_name: Simvastatin


subject: UMLS:C0007220

subject_name: Cardiovascular Agents


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: Neck Carcinoma


subject: CHEBI:168243

object_name: head and neck neoplasm


subject: CHEBI:168243

object_name: head and neck cancer


subject: CHEBI:168243

object_name: oropharyngeal carcinoma


subject: CHEBI:168243

object_name: oropharynx cancer


subject: CHEBI:168243

object_name: oral cavity carcinoma


subject: CHEBI:168243

object_name: oral cavity cancer


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: prostate cancer


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: endometrial cancer


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: uterine corpus cancer


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: endometrial carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: fibrolamellar hepatocellular carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: pediatric angiosarcoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: angiosarcoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Adult Angiosarcoma


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: UMLS:C4764272

subject_name: Botensilimab


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: UMLS:C0909027

subject_name: dai-kenchu-to

object_name: irritable bowel syndrome


subject: UMLS:C0909027

object_name: digestive system disorder


subject: UMLS:C0909027

object_name: intestinal disorder


subject: UMLS:C0909027

object_name: Abdominal pain


subject: UMLS:C0909027

object_name: Abdominal Pain, CTCAE


subject: UNII:N3KQ8A1E0X


subject: UNII:N3KQ8A1E0X


subject: UNII:N3KQ8A1E0X


subject: UNII:N3KQ8A1E0X


subject: UNII:N3KQ8A1E0X


subject: CHEMBL.COMPOUND:CHEMBL461806

subject_name: ELTROMBOPAG OLAMINE

object_name: thrombocytopenia


subject: UMLS:C1880492

subject_name: eltrombopag olamine


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: periodontitis, chronic, adult


subject: UNII:L500PR95QA

object_name: chronic periodontitis


subject: UNII:L500PR95QA

object_name: type 2 diabetes mellitus


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: UMLS:C3253508

object_name: Alzheimer disease


subject: UMLS:C1612488

subject_name: Xibrom

object_name: cataract


subject: UMLS:C1612488

object_name: Cataract, CTCAE 3.0


subject: UMLS:C1612488

object_name: Cataract, CTCAE 5.0


subject: UMLS:C1612488

object_name: cataract on exam (physical finding)


subject: CHEBI:31355

subject_name: Carboplatin

object_name: supratentorial primitive neuroectodermal tumor


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: PUBCHEM.COMPOUND:16760419

object_name: adult medulloblastoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:6067

subject_name: Isotretinoin


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A

object_name: Childhood Pineoblastoma


subject: UNII:T5IRO3534A

object_name: pineoblastoma


subject: UNII:T5IRO3534A

object_name: adult pineoblastoma


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716

object_name: medulloblastoma


subject: CHEBI:45716

object_name: childhood medulloblastoma


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: UMLS:C3534685

subject_name: Injection, aflibercept, 1 mg administered

object_name: retinal vein occlusion


subject: UMLS:C5203181

subject_name: Aflibercept Liquid Injection


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: orbital pseudotumor


subject: CHEBI:35812

subject_name: Oxfendazole

object_name: cysticercosis


subject: CHEBI:35812

object_name: Neurocysticercosis


subject: CHEBI:35812

object_name: Central Nervous System Cysticercosis


subject: UNII:TK9MSV53AD


subject: UNII:6D848RA61B

subject_name: Somatrogon

object_name: Congenital IGHD


subject: UNII:6D848RA61B

object_name: Reduced circulating growth hormone concentration


subject: MESH:C507879

subject_name: cytoflavin

object_name: diabetic neuropathy


subject: CHEBI:17596

subject_name: Inosine


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:57986


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:15741

subject_name: Succinic acid


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Squamous cell carcinoma of other specified sites of skin


subject: UNII:DPT0O3T46P

object_name: nasopharyngeal squamous cell carcinoma


subject: UMLS:C3883362

subject_name: Programmed Death Receptor-1 Blocking Antibody

object_name: Neck Carcinoma


subject: UMLS:C3883362

object_name: head and neck neoplasm


subject: UMLS:C3883362

object_name: head and neck cancer


subject: UMLS:C3883362


subject: UMLS:C3883362

object_name: oral cavity squamous cell carcinoma


subject: UMLS:C3883362


subject: UMLS:C3883362

object_name: laryngeal squamous cell carcinoma


subject: UMLS:C3883362

object_name: esophageal squamous cell carcinoma


subject: UMLS:C3883362

object_name: melanoma


subject: CHEBI:62932

subject_name: mycophenolate

object_name: pulmonary sarcoidosis


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: UNII:NTM296JU95


subject: UNII:NTM296JU95

object_name: head and neck squamous cell carcinoma


subject: CHEBI:8207

subject_name: Pilocarpine

object_name: outcomes general quality of life


subject: CHEBI:8207

object_name: Perceived quality of life


subject: CHEBI:8207

object_name: Good quality of life


subject: CHEBI:91414

subject_name: Adavosertib

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:91414

object_name: Esophageal adenocarcinoma stage IV


subject: CHEBI:91414

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:91414

object_name: Unresectable Esophageal Carcinoma


subject: CHEBI:91414

object_name: Metastatic Esophageal Squamous Cell Carcinoma


subject: CHEBI:91414

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Unresectable Esophageal Adenocarcinoma


subject: CHEBI:91414

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Unresectable Esophageal Squamous Cell Carcinoma


subject: CHEBI:91414

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: neoplastic meningitis


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Clinical Stage IV Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Clinical Stage III Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage III Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8


subject: CHEBI:91414

object_name: Distal Esophagus Adenocarcinoma


subject: CHEBI:91414

object_name: gastric cardia adenocarcinoma


subject: UMLS:C5814287

object_name: Hunter Syndrome


subject: CHEBI:16899

subject_name: Mannitol

object_name: bronchiectasis


subject: PUBCHEM.COMPOUND:56998

object_name: malaria


subject: UMLS:C4722543

subject_name: Toll-like Receptor 4 Agonist GLA-SE


subject: UMLS:C4722544

subject_name: Glucopyranosyl Lipid Adjuvant-Stable Emulsion


subject: UNII:53Z5E7R5KD

subject_name: STURLIMOGENE ERPAREPVEC

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:53Z5E7R5KD

object_name: Metastatic Renal Cell Cancer


subject: UNII:53Z5E7R5KD

object_name: Advanced renal cell carcinoma


subject: UNII:53Z5E7R5KD

object_name: Renal cell carcinoma recurrent


subject: UNII:53Z5E7R5KD

object_name: Clear-cell metastatic renal cell carcinoma


subject: UNII:53Z5E7R5KD

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UNII:53Z5E7R5KD

object_name: Advanced Clear Cell Renal Cell Carcinoma


subject: UNII:53Z5E7R5KD

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UNII:53Z5E7R5KD

object_name: Metastatic Sarcomatoid Renal Cell Carcinoma


subject: UNII:53Z5E7R5KD

object_name: Advanced Sarcomatoid Renal Cell Carcinoma


subject: CHEBI:91327

subject_name: Tivozanib


subject: CHEBI:91327


subject: CHEBI:91327


subject: CHEBI:91327


subject: CHEBI:91327


subject: CHEBI:91327


subject: CHEBI:5551

subject_name: Guaifenesin

object_name: Acute upper respiratory infection


subject: PUBCHEM.COMPOUND:53481562

subject_name: Gonadotropin-Releasing Hormone

object_name: complete trisomy 21


subject: PUBCHEM.COMPOUND:53481562

object_name: Down syndrome


subject: PUBCHEM.COMPOUND:53481562

object_name: anosmia


subject: PUBCHEM.COMPOUND:53481562

object_name: Mental deterioration


subject: PUBCHEM.COMPOUND:53481562

object_name: Cognitive impairment


subject: PUBCHEM.COMPOUND:53481562

object_name: Alzheimer Disease, Early Onset


subject: CHEBI:5520

subject_name: gonadorelin


subject: CHEBI:5520


subject: CHEBI:5520


subject: CHEBI:5520


subject: CHEBI:5520


subject: CHEBI:5520


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: UMLS:C0306166

subject_name: Factrel


subject: UMLS:C0306166


subject: UMLS:C0306166


subject: UMLS:C0306166


subject: UMLS:C0306166


subject: UMLS:C0306166


subject: PUBCHEM.COMPOUND:11980076

subject_name: GONADORELIN ACETATE


subject: PUBCHEM.COMPOUND:11980076


subject: PUBCHEM.COMPOUND:11980076


subject: PUBCHEM.COMPOUND:11980076


subject: PUBCHEM.COMPOUND:11980076


subject: PUBCHEM.COMPOUND:11980076


subject: UNII:2RG1XQ1NYJ


subject: UNII:2RG1XQ1NYJ


subject: UNII:2RG1XQ1NYJ


subject: UNII:2RG1XQ1NYJ


subject: UNII:2RG1XQ1NYJ


subject: UNII:2RG1XQ1NYJ


subject: UMLS:C0701918

subject_name: gonadorelin acetate


subject: UMLS:C0701918


subject: UMLS:C0701918


subject: UMLS:C0701918


subject: UMLS:C0701918


subject: UMLS:C0701918


subject: CHEBI:4856

subject_name: Esmolol

object_name: cardiogenic shock


subject: UNII:19EF2T21ST

object_name: sleep apnea


subject: CHEBI:3756

subject_name: Clonazepam

object_name: panic disorder


subject: CHEBI:3756

object_name: panic disorder 1


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Chronic Daily Headache


subject: UNII:7SQY4ZUD30

subject_name: Dinutuximab

object_name: Osteosarcoma


subject: UNII:7SQY4ZUD30

object_name: bone sarcoma


subject: UNII:7SQY4ZUD30

object_name: alveolar rhabdomyosarcoma


subject: UNII:7SQY4ZUD30

object_name: embryonal rhabdomyosarcoma


subject: UNII:7SQY4ZUD30

object_name: Childhood Embryonal Rhabdomyosarcoma


subject: CHEBI:27375

subject_name: Vinblastine

object_name: Kaposi Sarcoma


subject: CHEBI:132268

subject_name: Dacomitinib

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:132268

object_name: Non-small cell lung cancer stage IIIB


subject: CHEMBL.COMPOUND:CHEMBL5314628

subject_name: ELTREKIBART

object_name: ulcerative colitis


subject: CHEMBL.COMPOUND:CHEMBL5314628

object_name: inflammatory bowel disease 1


subject: CHEMBL.COMPOUND:CHEMBL5314628

object_name: Chronic ulcerative colitis


subject: UMLS:C5855315

subject_name: Eltrekibart


subject: UMLS:C5855315


subject: UMLS:C5855315


subject: UNII:19ORU63E06

object_name: bladder tumor


subject: UNII:19ORU63E06

object_name: urinary bladder carcinoma


subject: UNII:19ORU63E06

object_name: urinary bladder cancer


subject: UNII:19ORU63E06

object_name: childhood bladder carcinoma


subject: UNII:19ORU63E06

object_name: ureter cancer


subject: UNII:19ORU63E06

object_name: ureter carcinoma


subject: UNII:19ORU63E06

object_name: transitional cell carcinoma


subject: UNII:19ORU63E06

object_name: carcinoma of urethra


subject: UNII:19ORU63E06

object_name: urethra cancer


subject: UNII:19ORU63E06

object_name: renal pelvis carcinoma


subject: UNII:19ORU63E06

object_name: malignant renal pelvis neoplasm


subject: UMLS:C5555555

subject_name: Personalized Peptides-loaded Autologous Dendritic Cell Vaccine

object_name: pancreatic adenocarcinoma


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: aortic valve disease 2


subject: UMLS:C0001645

object_name: aortic stenosis


subject: UMLS:C0001645

object_name: aortic valve disease 3


subject: UMLS:C0001645

object_name: Stenosis of aorta


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic HER2-Positive Breast Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Breast adenocarcinoma metastatic


subject: UNII:52CMI0WC3Y

object_name: Recurrent HER2-Positive Breast Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Unresectable HER2-Positive Breast Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Unresectable Breast Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Breast adenocarcinoma recurrent


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:W9S9KZX5MD

subject_name: zastaprazan

object_name: Heartburn


subject: UMLS:C5669628

subject_name: Zastaprazan


subject: CHEBI:5775

subject_name: Hydralazine

object_name: Heart Failure, CTCAE


subject: CHEBI:2668

subject_name: Amlodipine

object_name: heart failure


subject: CHEBI:2668


subject: CHEBI:2668

object_name: congestive heart failure


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:3441

object_name: cardiac conduction defect


subject: CHEBI:3441

object_name: Ventricular Arrhythmia by ECG Finding


subject: CHEBI:3441

object_name: Ventricular arrhythmia


subject: CHEBI:3441

object_name: Ventricular Arrhythmia, CTCAE 5.0


subject: CHEBI:3441

object_name: Ventricular Arrhythmia, CTCAE 3.0


subject: CHEBI:3441

object_name: cardiomyopathy


subject: CHEBI:33704

subject_name: Amino acid

object_name: sarcopenia


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: autoimmune hemolytic anemia, warm type


subject: UMLS:C0295415

subject_name: rituximab


subject: GTOPDB:4934

subject_name: G-CSF

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: GTOPDB:4934

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: GTOPDB:4934

object_name: aplastic anemia


subject: GTOPDB:4934

object_name: idiopathic aplastic anemia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:93775

subject_name: Amethopterin

object_name: chronic leukemia


subject: CHEBI:93775

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:93775

object_name: myoclonic dystonia 11


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:135311

subject_name: Mitolactol

object_name: Febrile Neutropenia


subject: CHEBI:135311

object_name: Febrile Neutropenia, CTCAE


subject: UNII:K5E0V85NB9

subject_name: Carrimycin


subject: UMLS:C3661049

object_name: cocaine abuse


subject: CHEBI:16899

subject_name: Mannitol

object_name: hypotension of hemodialysis


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: vaginal cancer


subject: CHEBI:45863

object_name: vaginal carcinoma


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate

object_name: endometrial cancer


subject: CHEBI:32296

object_name: uterine corpus cancer


subject: CHEBI:32296

object_name: endometrial carcinoma


subject: CHEBI:32296

object_name: bladder tumor


subject: CHEBI:32296

object_name: urinary bladder carcinoma


subject: CHEBI:32296

object_name: urinary bladder cancer


subject: CHEBI:32296

object_name: childhood bladder carcinoma


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296

object_name: cervical cancer


subject: CHEBI:32296

object_name: cervical carcinoma


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:49086

object_name: Ischemic stroke


subject: CHEBI:16436

subject_name: Citicoline


subject: CHEBI:5134

subject_name: Fluticasone

object_name: bronchogenic carcinoma


subject: CHEBI:3996

subject_name: Cyclobenzaprine

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:3996

object_name: Back pain


subject: CHEBI:3996

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:3996

object_name: Muscle spasm


subject: CHEBI:3996

object_name: Hyperkinesia


subject: CHEBI:3996

object_name: Neck pain


subject: CHEBI:3996

object_name: Neck Pain, CTCAE 5.0


subject: CHEBI:3996

object_name: Neck Pain, CTCAE 3.0


subject: UMLS:C4724962

subject_name: PEG-conjugated TLR7/8 Agonist NKTR-262

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4724962

object_name: triple-negative breast carcinoma


subject: UMLS:C4724962

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4724962

object_name: trabecular adenocarcinoma


subject: UMLS:C4724962

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C4724962

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4724962

object_name: clear cell renal carcinoma


subject: UMLS:C4724962

object_name: renal cell adenocarcinoma


subject: UMLS:C4724962

object_name: renal cell carcinoma


subject: UMLS:C4724962

object_name: colorectal cancer


subject: UMLS:C4724962

object_name: colorectal carcinoma


subject: UMLS:C4724962

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4724962

object_name: melanoma


subject: UMLS:C4724962

object_name: malignant soft tissue neoplasm


subject: UMLS:C4724962

object_name: sarcoma


subject: GTOPDB:10659

subject_name: bempegaldesleukin


subject: GTOPDB:10659


subject: GTOPDB:10659


subject: GTOPDB:10659


subject: GTOPDB:10659


subject: GTOPDB:10659


subject: GTOPDB:10659


subject: GTOPDB:10659


subject: GTOPDB:10659


subject: GTOPDB:10659


subject: GTOPDB:10659


subject: GTOPDB:10659


subject: GTOPDB:10659


subject: GTOPDB:10659


subject: CHEMBL.COMPOUND:CHEMBL4298058

subject_name: BEMPEGALDESLEUKIN


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: CHEBI:50178

subject_name: chloroquine sulfate

object_name: Malaria, Vivax


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: pancreatic neoplasm


subject: UMLS:C0360094

object_name: exocrine pancreatic carcinoma


subject: UMLS:C0360094

object_name: malignant pancreatic neoplasm


subject: UMLS:C0360094

object_name: natural killer cell cytokine production


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:3249

object_name: metabolic syndrome X


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: retinal detachment


subject: UNII:15C2VL427D

object_name: Retinal Detachment, CTCAE 3.0


subject: UNII:15C2VL427D

object_name: Retinal Detachment, CTCAE 5.0


subject: CHEBI:60775

subject_name: Verteporfin


subject: CHEBI:60775


subject: CHEBI:60775


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEMBL.COMPOUND:CHEMBL5314346


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: Prostate Carcinoma Metastatic in the Soft Tissue


subject: CHEBI:63584

object_name: Adenocarcinoma of the prostate stage IV


subject: CHEBI:31709

subject_name: Iohexol

object_name: kidney disorder


subject: UMLS:C5417929

subject_name: IMU 838

object_name: ulcerative colitis


subject: UMLS:C5417929

object_name: inflammatory bowel disease 1


subject: UNII:3HO3IZ2ILX

object_name: diffuse large B-cell lymphoma


subject: UNII:3HO3IZ2ILX

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:3HO3IZ2ILX

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:73830

subject_name: Asp-Phe

object_name: Allergic rhinoconjunctivitis


subject: PR:000005376

subject_name: complement factor D


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: smoldering plasma cell myeloma


subject: CHEBI:17579

subject_name: Beta carotene

object_name: noise induced hearing loss


subject: CHEBI:17579

object_name: acoustic trauma (history)


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism


subject: UMLS:C3540792


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: PUBCHEM.COMPOUND:23724990

subject_name: Phytate Sodium

object_name: superficial siderosis


subject: PUBCHEM.COMPOUND:23724990

object_name: Superficial CNS hemosiderin deposition


subject: CHEBI:17596

subject_name: Inosine


subject: CHEBI:17596


subject: CHEBI:50730

subject_name: Montelukast

object_name: inherited susceptibility to asthma


subject: CHEBI:8378

subject_name: Prednisolone


subject: DRUGBANK:DB08937

object_name: Disseminated Malignant Neoplasm


subject: DRUGBANK:DB08937

object_name: Embolism, Tumor


subject: DRUGBANK:DB08937

object_name: Neoplasm Metastasis


subject: CHEBI:90876

subject_name: Lonsurf


subject: CHEBI:90876


subject: CHEBI:90876


subject: CHEBI:197437

subject_name: Mocetinostat

object_name: urothelial carcinoma


subject: CHEBI:197437

object_name: transitional cell carcinoma


subject: UNII:FN12T66RMN

subject_name: EFPREZIMOD ALFA

object_name: HIV infection


subject: UNII:FN12T66RMN

object_name: Dyslipidemia


subject: UMLS:C4287663


subject: UMLS:C4287663


subject: CHEBI:15355

subject_name: Acetylcholine

object_name: cancer


subject: CHEBI:15355

object_name: neoplasm


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: hypertension


subject: UNII:2S9ZZM9Q9V

object_name: Hypertension, CTCAE


subject: UNII:2S9ZZM9Q9V

object_name: coronary microvascular disorder


subject: UNII:169D1260KM

subject_name: NITROPRUSSIDE


subject: UNII:169D1260KM


subject: UNII:169D1260KM


subject: UNII:169D1260KM


subject: UNII:169D1260KM


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: UNII:41J7ZJ239R

object_name: leukemia


subject: UNII:41J7ZJ239R

object_name: childhood leukemia


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Fatigue, CTCAE 5.0


subject: UNII:FYS6T7F842

object_name: Fatigue


subject: CHEBI:232469

object_name: Pre T-ALL


subject: CHEBI:232469

object_name: Lymphoblastic T-cell lymphoma


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)


subject: CHEBI:75283

subject_name: Miltefosine

object_name: Brazilian; leishmaniasis


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Chiclero ulcer


subject: CHEBI:7986


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: melanoma


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: diabetes mellitus


subject: CHEBI:4806

object_name: hyperlipidemia


subject: CHEBI:4806

object_name: hyperlipoproteinemia


subject: CHEBI:4806

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:4806

object_name: Serum lipids high (finding)


subject: PUBCHEM.COMPOUND:262961

object_name: Premenstrual Dysphoric Disorder


subject: CHEBI:11909

subject_name: Sepranolone


subject: UMLS:C4764358

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3852555

object_name: Parkinson disease


subject: UMLS:C5557656

object_name: prostate carcinoma


subject: UMLS:C5557656

object_name: prostate cancer


subject: CHEBI:71013

subject_name: Perampanel

object_name: Suicidal ideation


subject: CHEBI:71013

object_name: Suicidal Ideation, CTCAE


subject: CHEBI:71013

object_name: endogenous depression


subject: CHEBI:71013

object_name: major depressive disorder


subject: CHEBI:71013

object_name: Depressed mood


subject: CHEBI:71013

object_name: post-traumatic stress disorder


subject: CHEBI:71013

object_name: bipolar disorder


subject: CHEBI:50858

subject_name: corticosteroid

object_name: Adverse effects


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: UNII:UR18YJ97SJ

object_name: Alzheimer disease


subject: CHEBI:180911

object_name: urinary bladder carcinoma


subject: CHEBI:180911

object_name: urinary bladder cancer


subject: CHEBI:180911

object_name: childhood bladder carcinoma


subject: CHEBI:45906

subject_name: Suramin


subject: CHEBI:45906


subject: CHEBI:45906


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: cholangitis


subject: CHEBI:63598

subject_name: Levofloxacin


subject: UMLS:C5706379

subject_name: Cytotoxic Agent-LAT1 Substrate QBS10072S

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C5706379

object_name: lung cancer


subject: UMLS:C5706379

object_name: lung neoplasm


subject: UMLS:C5706379

object_name: lung carcinoma


subject: UMLS:C5706379

object_name: Childhood Breast Carcinoma


subject: UMLS:C5706379

object_name: breast carcinoma


subject: UMLS:C5706379

object_name: breast cancer


subject: UMLS:C5706379

object_name: Langer mesomelic dysplasia


subject: UMLS:C5706379

object_name: Leptomeningeal Neoplasms


subject: UMLS:C0030304

subject_name: pancreatin

object_name: exocrine pancreatic insufficiency


subject: CHEBI:60799

subject_name: Esketamine

object_name: adverse effect


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: Sedentary lifestyle


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:8024

subject_name: Perindopril


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: psoriasis vulgaris


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:176334

object_name: Myelodysplasia


subject: CHEBI:176334

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:176334

object_name: childhood myelodysplastic syndrome


subject: CHEBI:176334

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:8499

subject_name: Propranolol

object_name: tardive dyskinesia


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: Light chain (AL) amyloidosis


subject: CHEBI:4806

object_name: Cardiac involvement


subject: PUBCHEM.COMPOUND:18442052

subject_name: Bis-choline tetrathiomolybdate

object_name: Wilson disease


subject: CHEBI:132967

subject_name: Elbasvir

object_name: BCLC Stage C Hepatocellular Carcinoma


subject: CHEBI:132967

object_name: BCLC Stage B Hepatocellular Carcinoma


subject: CHEBI:132967

object_name: Stage IV Hepatocellular Carcinoma AJCC v7


subject: CHEBI:132967

object_name: Stage III Hepatocellular Carcinoma AJCC v7


subject: CHEBI:132967

object_name: Stage IVB Hepatocellular Carcinoma AJCC v7


subject: CHEBI:132967

object_name: Stage IVA Hepatocellular Carcinoma AJCC v7


subject: CHEBI:132967

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v7


subject: CHEBI:132967

object_name: Stage IIIC Hepatocellular Carcinoma AJCC v7


subject: CHEBI:132967

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v7


subject: CHEBI:132967

object_name: Refractory Liver Carcinoma


subject: UNII:4O2AB118LA

subject_name: GRAZOPREVIR


subject: UNII:4O2AB118LA


subject: UNII:4O2AB118LA


subject: UNII:4O2AB118LA


subject: UNII:4O2AB118LA


subject: UNII:4O2AB118LA


subject: UNII:4O2AB118LA


subject: UNII:4O2AB118LA


subject: UNII:4O2AB118LA


subject: UNII:4O2AB118LA


subject: CHEBI:132975

subject_name: Grazoprevir


subject: CHEBI:132975


subject: CHEBI:132975


subject: CHEBI:132975


subject: CHEBI:132975


subject: CHEBI:132975


subject: CHEBI:132975


subject: CHEBI:132975


subject: CHEBI:132975


subject: CHEBI:132975


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: hepatitis C


subject: UNII:DPT0O3T46P


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:63580


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib

object_name: Clonal Cytopenia of Undetermined Significance


subject: UMLS:C0071315

subject_name: Pneumovax

object_name: COPD, severe early onset


subject: UMLS:C0071315

object_name: chronic obstructive pulmonary disease


subject: MESH:C414006

subject_name: 23-valent pneumococcal capsular polysaccharide vaccine


subject: MESH:C414006


subject: RXCUI:287523

subject_name: Pneumovax 23


subject: RXCUI:287523


subject: UMLS:C0876134

subject_name: Prevnar


subject: UMLS:C0876134


subject: CHEBI:8988

object_name: Refractory Lymphoma


subject: CHEBI:8988

object_name: Recurrent Lymphoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:93776

subject_name: Pevonedistat


subject: CHEBI:93776


subject: CHEBI:93776

object_name: Refractory Primary Central Nervous System Neoplasm


subject: CHEBI:93776

object_name: Recurrent Primary Central Nervous System Neoplasm


subject: CHEBI:93776

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:93776

object_name: Recurrent Malignant Solid Neoplasm


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:139072

object_name: bipolar disorder


subject: CHEBI:139072

object_name: bipolar depression


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: PUBCHEM.COMPOUND:35023177

subject_name: Carboprost Tromethamine

object_name: uterine fibroid


subject: PUBCHEM.COMPOUND:35023177

object_name: female reproductive system disorder


subject: PUBCHEM.COMPOUND:5229711

subject_name: Carboprost


subject: PUBCHEM.COMPOUND:5229711


subject: UMLS:C5449237

subject_name: Lipid Injectable Emulsion

object_name: Essential fatty acid deficiency


subject: UMLS:C5449237


subject: UMLS:C5449237

object_name: malnutrition


subject: UMLS:C5449237

object_name: Child Malnutrition


subject: CHEBI:6413

subject_name: Letrozole

object_name: Blighted ovum


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Metastasis


subject: CHEBI:233362

object_name: Metastatic Lesion


subject: CHEBI:144094

subject_name: bicalutamide


subject: CHEBI:10034

subject_name: warfarin sodium

object_name: atrial fibrillation


subject: CHEBI:10034

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:10034

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:10034

object_name: pulmonary embolism


subject: CHEBI:10034

object_name: Deep Venous Thrombosis Related to COVID-19


subject: CHEBI:10034

object_name: Deep venous thrombosis


subject: MESH:C000632580

subject_name: TheraCal

object_name: dental caries


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Anaesthesia intubation complication


subject: CHEBI:6129

object_name: tracheal disorder


subject: MESH:D000074262

subject_name: Rapeseed Oil

object_name: hypercholesterolemia, familial, 1


subject: MESH:D000074262

object_name: familial hypercholesterolemia


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: biliary atresia


subject: UMLS:C4745318

subject_name: CXA 201

object_name: Complicated intra-abdominal infection


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: chronic neutrophilic leukemia


subject: CHEBI:66919

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: UMLS:C1329986

subject_name: BUPIVACAINE/FENTANYL

object_name: renal carcinoma


subject: UMLS:C1329986

object_name: kidney neoplasm


subject: UMLS:C1329986

object_name: kidney cancer


subject: UMLS:C1329986

object_name: Surgical procedure finding


subject: UMLS:C1329986

object_name: Arrhythmia


subject: CHEBI:231594

subject_name: Norgestrel

object_name: isthmocele


subject: CHEBI:231594

object_name: pelvic pain on the left


subject: CHEBI:231594

object_name: pelvic pain occurs with urination


subject: CHEBI:231594

object_name: pelvic pain occurs with bowel movement


subject: CHEBI:231594

object_name: pelvic pain decreasing in severity


subject: CHEBI:231594

object_name: Pelvic pain female


subject: CHEBI:231594

object_name: pelvic pain increasing in severity


subject: CHEBI:231594

object_name: male pelvic pain


subject: CHEBI:231594

object_name: pelvic pain to the rear


subject: CHEBI:231594

object_name: pelvic pain on the right


subject: CHEBI:231594

object_name: pelvic pain decreasing in frequency


subject: CHEBI:231594

object_name: Pelvic pain


subject: CHEBI:231594

object_name: Pelvic Pain, CTCAE 5.0


subject: CHEBI:231594

object_name: pelvic pain causes awakening at night


subject: CHEBI:231594

object_name: pelvic pain increasing in frequency


subject: CHEBI:231594

object_name: pelvic pain occurs with intercourse


subject: CHEBI:231594

object_name: pelvic pain in front


subject: CHEBI:10033

subject_name: Warfarin

object_name: Pulmonary Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:138376495

subject_name: Cefiderocol

object_name: Infection of bloodstream


subject: PUBCHEM.COMPOUND:138376495

object_name: VABP


subject: PUBCHEM.COMPOUND:138376495

object_name: Hospital acquired bacterial pneumonia


subject: PUBCHEM.COMPOUND:138376495

object_name: Multi-Drug Resistance


subject: CHEBI:85989

subject_name: Avycaz


subject: CHEBI:85989

object_name: Sepsis


subject: CHEBI:85989


subject: CHEBI:85989


subject: CHEBI:85989

object_name: Infection caused by carbapenem resistant bacteria


subject: CHEBI:85989


subject: UMLS:C3656596

subject_name: avibactam / ceftazidime


subject: UMLS:C3656596


subject: UMLS:C3656596


subject: UMLS:C3656596


subject: UMLS:C3656596


subject: UMLS:C3656596


subject: CHEBI:161680

subject_name: Aztreonam


subject: CHEBI:161680


subject: CHEBI:161680


subject: CHEBI:161680


subject: CHEBI:161680


subject: CHEBI:161680


subject: PUBCHEM.COMPOUND:76322320

subject_name: COLISTIN


subject: PUBCHEM.COMPOUND:76322320


subject: PUBCHEM.COMPOUND:76322320


subject: PUBCHEM.COMPOUND:76322320


subject: PUBCHEM.COMPOUND:76322320


subject: CHEBI:37943

subject_name: colistin


subject: CHEBI:37943


subject: CHEBI:37943


subject: CHEBI:37943


subject: CHEBI:37943


subject: PUBCHEM.COMPOUND:134129840

subject_name: POLYMYXIN B


subject: PUBCHEM.COMPOUND:134129840


subject: PUBCHEM.COMPOUND:134129840


subject: PUBCHEM.COMPOUND:134129840


subject: PUBCHEM.COMPOUND:134129840


subject: PUBCHEM.COMPOUND:134129840


subject: PUBCHEM.COMPOUND:4868

subject_name: polymyxin B


subject: PUBCHEM.COMPOUND:4868


subject: PUBCHEM.COMPOUND:4868


subject: PUBCHEM.COMPOUND:4868


subject: PUBCHEM.COMPOUND:4868


subject: PUBCHEM.COMPOUND:4868


subject: CHEMBL.COMPOUND:CHEMBL5314354


subject: CHEMBL.COMPOUND:CHEMBL5314354


subject: CHEMBL.COMPOUND:CHEMBL5314354


subject: CHEMBL.COMPOUND:CHEMBL5314354


subject: CHEMBL.COMPOUND:CHEMBL5314354


subject: CHEMBL.COMPOUND:CHEMBL5314354


subject: PUBCHEM.COMPOUND:3417


subject: PUBCHEM.COMPOUND:3417


subject: PUBCHEM.COMPOUND:3417


subject: PUBCHEM.COMPOUND:3417


subject: PUBCHEM.COMPOUND:3417


subject: PUBCHEM.COMPOUND:3417


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62247


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:62419


subject: CHEBI:28915

subject_name: Fosfomycin


subject: CHEBI:28915


subject: CHEBI:28915


subject: CHEBI:28915


subject: CHEBI:28915


subject: CHEBI:28915


subject: PUBCHEM.COMPOUND:5316

subject_name: Sulbactam


subject: PUBCHEM.COMPOUND:5316


subject: PUBCHEM.COMPOUND:5316


subject: PUBCHEM.COMPOUND:5316


subject: PUBCHEM.COMPOUND:5316


subject: PUBCHEM.COMPOUND:172973390

subject_name: Ceftolozane-tazobactam


subject: PUBCHEM.COMPOUND:172973390


subject: PUBCHEM.COMPOUND:172973390


subject: PUBCHEM.COMPOUND:172973390


subject: PUBCHEM.COMPOUND:172973390


subject: PUBCHEM.COMPOUND:172973390


subject: UMLS:C3656593

subject_name: ceftolozane / tazobactam


subject: UMLS:C3656593


subject: UMLS:C3656593


subject: UMLS:C3656593


subject: UMLS:C3656593


subject: UMLS:C3656593


subject: CHEBI:6770

subject_name: MEROPENEM


subject: CHEBI:6770


subject: CHEBI:6770


subject: CHEBI:6770


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:142708


subject: CHEBI:142708


subject: CHEBI:142708


subject: CHEBI:142708


subject: CHEBI:142708


subject: CHEBI:142708


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: PUBCHEM.COMPOUND:54686904


subject: PUBCHEM.COMPOUND:54686904


subject: PUBCHEM.COMPOUND:54686904


subject: PUBCHEM.COMPOUND:54686904


subject: PUBCHEM.COMPOUND:54686904


subject: CHEBI:149836

subject_name: Tigecycline


subject: CHEBI:149836


subject: CHEBI:149836


subject: CHEBI:149836


subject: CHEBI:149836


subject: CHEBI:149836


subject: PUBCHEM.COMPOUND:76211403

subject_name: Eravacycline


subject: PUBCHEM.COMPOUND:76211403


subject: PUBCHEM.COMPOUND:76211403


subject: PUBCHEM.COMPOUND:76211403


subject: PUBCHEM.COMPOUND:76211403


subject: PUBCHEM.COMPOUND:76211403


subject: UNII:07896928ZC


subject: UNII:07896928ZC


subject: UNII:07896928ZC


subject: UNII:07896928ZC


subject: UNII:07896928ZC


subject: UNII:07896928ZC


subject: UMLS:C4482910

subject_name: meropenem / vaborbactam


subject: UMLS:C4482910


subject: UMLS:C4482910


subject: UMLS:C4482910


subject: UMLS:C4482910


subject: UMLS:C4482910


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: Pre T-ALL


subject: UMLS:C0699319

object_name: T-cell leukemia


subject: UMLS:C0699319

object_name: T-Cell Lymphoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:31797

subject_name: Gadolinium DTPA

object_name: Renal artery stenosis


subject: CHEBI:180856

subject_name: Hovenoside G


subject: UMLS:C0721529

subject_name: Magnevist


subject: UMLS:C0771948

subject_name: Fosfomycin sodium

object_name: urinary tract infection


subject: UMLS:C0771948

object_name: bacterial urinary tract infection


subject: UMLS:C0771948

object_name: Urinary Tract Infection, CTCAE


subject: UMLS:C0771948

object_name: Asymptomatic bacteriuria


subject: CHEBI:9984

subject_name: vincaleukoblastine sulfate

object_name: Recurrent WHO Grade 2 Glioma


subject: CHEBI:9984

object_name: Refractory Low Grade Glioma


subject: CHEBI:9984

object_name: Recurrent Low Grade Astrocytoma


subject: CHEBI:9984

object_name: Refractory WHO Grade 1 Glioma


subject: CHEBI:9984

object_name: Refractory Low Grade Astrocytoma


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:60269

subject_name: trisodium phosphonoformate hexahydrate

object_name: digestive system disorder


subject: CHEBI:127780

subject_name: Foscarnet


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Fatal Outcome


subject: UNII:5S371K6132

object_name: Surgical procedure finding


subject: CHEBI:82339

object_name: follicular lymphoma


subject: CHEBI:82339

object_name: Aggressive Non-Hodgkin Lymphoma


subject: CHEBI:28876


subject: UMLS:C5854539

subject_name: Anti-PD-L1/4-1BB Bispecific Antibody QLF31907

object_name: Childhood Solid Neoplasm


subject: UMLS:C5854539

object_name: Adult Solid Neoplasm


subject: UMLS:C5854539

object_name: Solid Neoplasm


subject: UMLS:C5854539

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5854539

object_name: non-Hodgkin lymphoma


subject: UNII:2P6O7CFW5K

subject_name: Triheptanoin

object_name: medium chain acyl-CoA dehydrogenase deficiency


subject: UMLS:C1950973

subject_name: Arnica Ointment

object_name: Skin Bruise


subject: UMLS:C1950973

object_name: Easy Bruising


subject: UMLS:C1950973

object_name: Ecchymosis


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class


subject: UMLS:C3714648


subject: UMLS:C3714648


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: UMLS:C3541380


subject: UMLS:C3541380


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:28384


subject: CHEBI:28384


subject: CHEBI:18067

subject_name: Phylloquinone


subject: CHEBI:18067


subject: CHEBI:18067


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: UMLS:C2936884


subject: UMLS:C2936884


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch


subject: UMLS:C0358855

object_name: SARS-associated coronavirus as cause of disease classified elsewhere


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Stage 1 chronic kidney disease


subject: CHEBI:89324

object_name: Stage 2 chronic kidney disease


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:7476

subject_name: Naproxen

object_name: Muscle strain, multiple sites


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Myocardial injury


subject: CHEBI:6801

subject_name: Metformin

object_name: neuroendocrine neoplasm


subject: CHEBI:50853

subject_name: quantum dot

object_name: AIDS


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: neoplasm


subject: CHEBI:681569

subject_name: Clofarabine

object_name: cancer


subject: UMLS:C3827186

subject_name: Jobelyn

object_name: Schizophrenia Spectrum and Other Psychotic Disorders


subject: UNII:9TD681796G

subject_name: Sitafloxacin

object_name: mycobacterial infectious disease


subject: CHEBI:4304

subject_name: sitafloxacin


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: COPD, severe early onset


subject: DRUGBANK:DB16738

subject_name: Ciltacabtagene autoleucel

object_name: Plasma cell myeloma recurrent


subject: CHEBI:57694

object_name: Plasma cell myeloma refractory


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:38562

subject_name: Fluvastatin

object_name: autoimmune polyendocrinopathy


subject: CHEBI:38562

object_name: antiphospholipid syndrome


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Multiple Trauma


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid